Phenomenex Unveils New LC Column Connector for Optimized LC and Low-Flow Separations
Provides high-precision LC column connectivity to achieve consistent chromatography results TORRANCE, Calif., May 28, 2025 /PRNewswire/ -- Phenomenex Inc., a...
Day: May 28, 2025
SDFM Launches New CDFM-H Credential to Strengthen Defense Healthcare Financial Management
ALEXANDRIA, Va., May 28, 2025 /PRNewswire/ -- The Society of Defense Financial Management (SDFM) is proud to announce the launch of...
Research Solutions To Present In The 2025 Virtual Tech Conference Presented By Maxim Group LLC
HENDERSON, Nev., May 28, 2025 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a leading provider of AI-powered scientific research tools, announced today...
FlyteHealth Obesity Care Program Demonstrates Cost Avoidance and Noteworthy Medication Adherence in Year-One Outcomes
NEW CANAAN, Conn., May 28, 2025 /PRNewswire/ -- FlyteHealth, a leading virtual cardiometabolic care provider, announced year-one outcomes from its Comprehensive...
Sellers Dorsey Appoints Jennifer Duke as Chief Growth Officer
Industry veteran to lead Sellers Dorsey's next chapter of growth, advancing data-informed strategies across public and private health sectors PHILADELPHIA,...
IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography
MELBOURNE, Australia, May 28, 2025 /PRNewswire/ -- IonOpticks, developer of the highest-performing chromatography columns for mass spectrometry research, today announces...
Helia Care and Lifepoint Health Complete the System-Wide Rollout of Novel Transaction Solution that Solves Legacy Healthcare Purchasing Problem
The company's network-based digital handshake has already reduced the health system's not-on-contract spend by 50%. SCOTTSDALE, Ariz., May 28, 2025...
Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040
RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone...
Olympia Pharmaceuticals Secures $637,000 Workforce Training Grant to Boost Job Creation in Orlando
The funding will train 100 new employees at Wesley Pharmaceuticals, supporting local talent and healthcare innovation in Orlando Wesley Pharmaceuticals...
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project...
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a...
PacBio to Present at Upcoming Investor Conferences
MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing...
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to...
HCVC leads kyron.bio €5.5M round to use glycan engineering for advanced drug design
The company has developed the first-ever platform to unlock precision control over glycans, essential sugar molecules found on the surface...
Alpha Tau to Present at Jefferies Global Healthcare Conference
JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the...
iTeos Therapeutics Announces Its Intention to Wind Down Operations
- Board of Directors intends to cease operations - Company to focus efforts on selecting best path to deliver near-term...
Vittoria Biotherapeutics to Share Trials-in-Progress Presentation from Phase 1 Study of VIPER-101 at ASCO 2025 Annual Meeting
Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T-cell lymphomaPHILADELPHIA, May 28, 2025...
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical holdResumption of dosing in...
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood...
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty...